Your Funds at Work

Prior to 2020, funds raised went to the Sarcoma Foundation of America to support sarcoma research nationally and locally. Fifty percent of the net proceeds supported the University of Pittsburgh Cancer Institute Sarcoma Research Fund through a restricted sarcoma research grant. The other fifty percent of net proceeds were delegated to sarcoma research grants throughout the country, at the discretion of the SFA. In total, Pittsburgh Cure Sarcoma races have funded eight sarcoma research grants through the SFA:

2013

Pittsburgh 5K Cure Sarcoma Research Grant
Brian Van Tine, MD, PhD
Washington University, St. Louis
“A metabolomic approach to targeting ASS1 deficient sarcomas”

2014

Pittsburgh 5K Cure Sarcoma Research Grant
Liang-Chuan Wang, PhD
University of Pennsylvania
“CAR T Cell Therapy for Sarcoma”

2015

Pittsburgh Cure Sarcoma Co-Founder Carl Firetto Memorial Research Award
Meenakshi Hegde, MD
Baylor College of Medicine
“Adoptive cellular therapy for Ewing’s sarcoma”

Pittsburgh Cure Sarcoma Co-Founder Bill Suit Memorial Research Award
Steven Katz, MD
Roger Williams Hospital
“Pre-clinical development of anti-KIT CAR-Ts for metastatic GIST”

2016

Pittsburgh Cure Sarcoma Co-Founder Carl Firetto Memorial Research Award
William Karl Decker, PhD
Baylor College of Medicine
“Outbred Canine Model of Adjuvant Immunotherapy for Angiosarcoma”

Pittsburgh Cure Sarcoma Co-Founder Bill Suit Memorial Research Award
Lionel Mu-Lo Chow, MD, PhD
Cincinnati Children’s Hospital Medical Center
“A Novel Genetically Engineered Mouse Model for Angiosarcoma: Molecular Characterization and Comparison to Human Angiosarcoma to Develop Targeted Therapy”

2017

Pittsburgh Cure Sarcoma Research Award
Cheryl London, DVM, PhD
Tufts Medical Center
“Interrogating the regulation, function and therapeutic potential of monocarboxylate transporters in osteosarcoma”

2018

Pittsburgh Cure Sarcoma Research Award
Maria Paola Paronetto, PhD
IRCCS Santa Lucia Foundation
“Global impact of the DNA/RNA helicase DHX9 on the processing of coding and noncoding transcripts in Ewing sarcoma pathogenesis”